PubMed:31341019
Annnotations
PubMed_ArguminSci
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 154-319 | DRI_Background | denotes | The triple-negative phenotype is the most prevalent form of human breast cancer worldwide and is characterized by poor survival, high aggressiveness, and recurrence. |
| T2 | 320-483 | DRI_Background | denotes | Microvesicles (MV) are shredded plasma membrane components and critically mediate cell-cell communication, but can also induce cancer proliferation and metastasis. |
| T3 | 484-725 | DRI_Background | denotes | Previous studies have revealed that protease-activated receptor 2 (PAR2) contributes significantly to human triple-negative breast cancer (TNBC) progression by releasing nano-size MV and promoting cell proliferation, migration, and invasion. |
| T4 | 726-829 | DRI_Background | denotes | MV isolated from highly aggressive human TNBC cells impart metastatic potential to nonmetastatic cells. |
| T5 | 830-1000 | DRI_Background | denotes | Over-expression of microRNA221 (miR221) has also been reported to enhance the metastatic potential of human TNBC, but miR221's relationship to PAR2-induced MV is unclear. |
| T6 | 1001-1342 | DRI_Outcome | denotes | Here, using isolated MV, immunoblotting, quantitative RT-PCR, FACS analysis, and enzymatic assays, we show that miR221 is translocated via human TNBC-derived MV, which upon fusion with recipient cells, enhance their proliferation, survival, and metastasis both in vitro and in vivo by inducing the epithelial-to-mesenchymal transition (EMT). |
| T7 | 1343-1572 | DRI_Background | denotes | Administration of anti-miR221 significantly impaired MV-induced expression of the mesenchymal markers Snail, Slug, N-cadherin, and vimentin in the recipient cells, whereas restoring expression of the epithelial marker E-cadherin. |
| T8 | 1573-1597 | DRI_Outcome | denotes | We also demonstrate that |
| T9 | 1619-1763 | DRI_Outcome | denotes | targets phosphatase and tensin homolog (PTEN) in the recipient cells, followed by AKT Ser/Thr kinase (AKT)/NF-κB activation, which promotes EMT. |
| T10 | 1764-1909 | DRI_Background | denotes | Moreover, elevated miR221 levels in MV derived from human TNBC patients' blood could induce cell proliferation and metastasis in recipient cells. |
| T11 | 1910-2042 | DRI_Approach | denotes | In summary, miR221 transfer from TNBC cells via PAR2-derived MV induces EMT and enhances the malignant potential of recipient cells. |
sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-153 | Sentence | denotes | Triple-negative breast cancer-derived microvesicles transfer microRNA221 to the recipient cells and thereby promote epithelial-to-mesenchymal transition. |
| T2 | 154-319 | Sentence | denotes | The triple-negative phenotype is the most prevalent form of human breast cancer worldwide and is characterized by poor survival, high aggressiveness, and recurrence. |
| T3 | 320-483 | Sentence | denotes | Microvesicles (MV) are shredded plasma membrane components and critically mediate cell-cell communication, but can also induce cancer proliferation and metastasis. |
| T4 | 484-725 | Sentence | denotes | Previous studies have revealed that protease-activated receptor 2 (PAR2) contributes significantly to human triple-negative breast cancer (TNBC) progression by releasing nano-size MV and promoting cell proliferation, migration, and invasion. |
| T5 | 726-829 | Sentence | denotes | MV isolated from highly aggressive human TNBC cells impart metastatic potential to nonmetastatic cells. |
| T6 | 830-1000 | Sentence | denotes | Over-expression of microRNA221 (miR221) has also been reported to enhance the metastatic potential of human TNBC, but miR221's relationship to PAR2-induced MV is unclear. |
| T7 | 1001-1342 | Sentence | denotes | Here, using isolated MV, immunoblotting, quantitative RT-PCR, FACS analysis, and enzymatic assays, we show that miR221 is translocated via human TNBC-derived MV, which upon fusion with recipient cells, enhance their proliferation, survival, and metastasis both in vitro and in vivo by inducing the epithelial-to-mesenchymal transition (EMT). |
| T8 | 1343-1572 | Sentence | denotes | Administration of anti-miR221 significantly impaired MV-induced expression of the mesenchymal markers Snail, Slug, N-cadherin, and vimentin in the recipient cells, whereas restoring expression of the epithelial marker E-cadherin. |
| T9 | 1573-1763 | Sentence | denotes | We also demonstrate that MV-associated miR221 targets phosphatase and tensin homolog (PTEN) in the recipient cells, followed by AKT Ser/Thr kinase (AKT)/NF-κB activation, which promotes EMT. |
| T10 | 1764-1909 | Sentence | denotes | Moreover, elevated miR221 levels in MV derived from human TNBC patients' blood could induce cell proliferation and metastasis in recipient cells. |
| T11 | 1910-2042 | Sentence | denotes | In summary, miR221 transfer from TNBC cells via PAR2-derived MV induces EMT and enhances the malignant potential of recipient cells. |
Glycosmos6-MAT
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 1837-1842 | http://purl.obolibrary.org/obo/MAT_0000083 | denotes | blood |
| T2 | 1837-1842 | http://purl.obolibrary.org/obo/MAT_0000315 | denotes | blood |
HP-phenotype
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T1 | 16-29 | Phenotype | denotes | breast cancer | HP:0003002 |
| T2 | 220-233 | Phenotype | denotes | breast cancer | HP:0003002 |
| T3 | 288-302 | Phenotype | denotes | aggressiveness | HP:0000718 |
| T4 | 447-453 | Phenotype | denotes | cancer | HP:0002664 |
| T5 | 608-621 | Phenotype | denotes | breast cancer | HP:0003002 |
| T6 | 750-760 | Phenotype | denotes | aggressive | HP:0000718 |
mondo_disease
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T1 | 0-29 | Disease | denotes | Triple-negative breast cancer | http://purl.obolibrary.org/obo/MONDO_0005494 |
| T2 | 220-233 | Disease | denotes | breast cancer | http://purl.obolibrary.org/obo/MONDO_0007254 |
| T3 | 447-453 | Disease | denotes | cancer | http://purl.obolibrary.org/obo/MONDO_0004992 |
| T4 | 592-621 | Disease | denotes | triple-negative breast cancer | http://purl.obolibrary.org/obo/MONDO_0005494 |
| T5 | 623-627 | Disease | denotes | TNBC | http://purl.obolibrary.org/obo/MONDO_0005494 |
| T6 | 767-771 | Disease | denotes | TNBC | http://purl.obolibrary.org/obo/MONDO_0005494 |
| T7 | 938-942 | Disease | denotes | TNBC | http://purl.obolibrary.org/obo/MONDO_0005494 |
| T8 | 1063-1067 | Disease | denotes | FACS | http://purl.obolibrary.org/obo/MONDO_0018262 |
| T9 | 1146-1150 | Disease | denotes | TNBC | http://purl.obolibrary.org/obo/MONDO_0005494 |
| T10 | 1822-1826 | Disease | denotes | TNBC | http://purl.obolibrary.org/obo/MONDO_0005494 |
| T11 | 1943-1947 | Disease | denotes | TNBC | http://purl.obolibrary.org/obo/MONDO_0005494 |
NCBITAXON
| Id | Subject | Object | Predicate | Lexical cue | db_id |
|---|---|---|---|---|---|
| T1 | 214-219 | OrganismTaxon | denotes | human | 9606 |
| T2 | 586-591 | OrganismTaxon | denotes | human | 9606 |
| T3 | 761-766 | OrganismTaxon | denotes | human | 9606 |
| T4 | 932-937 | OrganismTaxon | denotes | human | 9606 |
| T5 | 1140-1145 | OrganismTaxon | denotes | human | 9606 |
| T6 | 1816-1821 | OrganismTaxon | denotes | human | 9606 |
Anatomy-MAT
| Id | Subject | Object | Predicate | Lexical cue | mat_id |
|---|---|---|---|---|---|
| T1 | 1837-1842 | Body_part | denotes | blood | http://purl.obolibrary.org/obo/MAT_0000083|http://purl.obolibrary.org/obo/MAT_0000315 |
Anatomy-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T1 | 16-22 | Body_part | denotes | breast | http://purl.obolibrary.org/obo/UBERON_0000310 |
| T2 | 220-226 | Body_part | denotes | breast | http://purl.obolibrary.org/obo/UBERON_0000310 |
| T3 | 352-367 | Body_part | denotes | plasma membrane | http://purl.obolibrary.org/obo/GO_0005886 |
| T4 | 608-614 | Body_part | denotes | breast | http://purl.obolibrary.org/obo/UBERON_0000310 |
| T5 | 1837-1842 | Body_part | denotes | blood | http://purl.obolibrary.org/obo/UBERON_0000178 |